SCHEMBL17410802

SCHEMBL17410802

CC(C)(C)OC(=O)Oc1c(Br)ccc(O)c1C(=O)O

nearest known ligand 0.40

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ ELANE P08246 1/20 0.40
▸ CA2 P00918 3/20 0.34
▸ CA12 O43570 2/20 0.34
▸ CA1 P00915 2/20 0.34
▸ CA9 Q16790 2/20 0.34
▸ CA14 Q9ULX7 2/20 0.34
▸ CA7 P43166 1/20 0.34
▸ TPMT P51580 1/20 0.33
▸ THRA P10827 1/20 0.32
▸ THRB P10828 1/20 0.32
▸ KDM1A O60341 1/20 0.31
▸ GLRA3 O75311 1/20 0.30
▸ GLRB P48167 1/20 0.30
▸ MEN1 O00255 1/20 0.30
▸ NPC1 O15118 1/20 0.30
▸ HTT P42858 1/20 0.30
▸ RAB9A P51151 1/20 0.30
▸ KMT2A Q03164 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18857953 0.88 ELANE (0.40) ELANECA2CA12CA1CA9
SCHEMBL18089428 0.85 ELANE (0.40) ELANECA2CA12CA1CA9
SCHEMBL17410803 0.80 TSHR (0.40) ELANECA9THRBMEN1HTT
SCHEMBL18089677 0.79 ELANE (0.35) ELANECA2MEN1HTTKMT2A
SCHEMBL31006018 0.78 ELANE (0.41) ELANECA2CA12CA1CA9
SCHEMBL18857950 0.78 ELANE (0.41) ELANECA2CA12CA1CA9
SCHEMBL31617775 0.77 ELANE (0.40) ELANECA2CA12CA1CA9
SCHEMBL18263215 0.76 ELANE (0.47) ELANECA2CA12CA1CA9
SCHEMBL23414048 0.75 ELANE (0.39) ELANECA2CA12CA1CA9
SCHEMBL18857933 0.75 ELANE (0.39) ELANECA2CA12CA1CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2016149393-A1 BORONIC ACID DERIVATIVES AND THERAPEUTIC USES THEREOF REMPEX PHARMACEUTICALS, INC. (US) 2016-09-22 — — WO disclosed
WO-2016003929-A1 BORONIC ACID DERIVATIVES AND THERAPEUTIC USES THEREOF REMPEX PHARMACEUTICALS, INC. (US) 2016-01-07 — — WO disclosed
Send feedback